Ixazomib and Rituximab in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma

Name: Ixazomib and Rituximab in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma
License: Public Domain

M.D. Anderson Cancer Center

ClinicalTrials.gov · Datasets · License: Public Domain

recurrent mantle cell lymphoma, refractory mantle cell lymphoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 158230
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.